日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting the atypical chemokine receptor 2 (Ackr2) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model.

靶向非典型趋化因子受体 2 (Ackr2) 可提高抗 PD-1 免疫疗法在黑色素瘤小鼠模型中的疗效

Noman Muhammad Zaeem, Szpakowska Martyna, Xiao Malina, Gao Ruize, Van Moer Kris, Kumar Akinchan, Ollert Markus, Berchem Guy, Chevigné Andy, Janji Bassam

Cryopreserved ovarian tissue autotransplantation in an acute myeloid leukaemia survivor following extensive minimal residual disease screening: first reported live birth in Europe

急性髓系白血病幸存者在接受广泛的微小残留病灶筛查后,进行冷冻保存的卵巢组织自体移植,并成功分娩:欧洲首例报道。

Soares, Michelle; Segers, Ingrid; De Brucker, Michael; Camboni, Alessandra; Hossay, Camille; Mateizel, Ileana; De Quick, Iebe; Van Moer, Ellen; Selleslag, Dominik; Hellebaut, Steven; Dolmans, Marie-Madeleine; De Vos, Michel

PEGylation of polymerized albumin retains colloid osmotic pressure: Towards an enhanced potential plasma substitute

聚乙二醇化修饰的聚合白蛋白可维持胶体渗透压:迈向更优的血浆代用品

Abdalbaqi, Amna; Yahya, Ahmad; Govender, Krianthan; Muñoz, Carlos; Van Moer, Gala Sanchez; Lucas, Daniela; Cabrales, Pedro; Palmer, Andre F

OPENPichia: licence-free Komagataella phaffii chassis strains and toolkit for protein expression

OPENPichia:无需许可证的 Komagataella phaffii 底盘菌株和蛋白质表达工具包

Katrien Claes #, Dries Van Herpe #, Robin Vanluchene #, Charlotte Roels, Berre Van Moer, Elise Wyseure, Kristof Vandewalle, Hannah Eeckhaut, Semiramis Yilmaz, Sandrine Vanmarcke, Erhan Çıtak, Daria Fijalkowska, Hendrik Grootaert, Chiara Lonigro, Leander Meuris, Gitte Michielsen, Justine Naessens, Lo

Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34

通过抑制自噬相关蛋白VPS34来改善基于STING激动剂的癌症疗法

Bartolini, Elisabetta; Van Moer, Kris; Janji, Bassam

Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy

VPS34抑制剂与STING激动剂联用可增强I型干扰素信号传导和抗肿瘤疗效

Yasmin Yu ,Madhumita Bogdan ,Muhammad Zaeem Noman ,Santiago Parpal ,Elisabetta Bartolini ,Kris Van Moer ,Simone Caroline Kleinendorst ,Kristine Bilgrav Saether ,Lionel Trésaugues ,Camilla Silvander ,Johan Lindström ,Jodi Simeon ,Mary Jane Timson ,Hikmat Al-Hashimi ,Bryan D Smith ,Daniel L Flynn ,Andrey Alexeyenko ,Jenny Viklund ,Martin Andersson ,Jessica Martinsson ,Katja Pokrovskaja Tamm ,Angelo De Milito ,Bassam Janji

Unleashing anti-tumor immunity: Targeting the autophagy-related protein VPS34 to enhance STING agonist-based therapy

激活抗肿瘤免疫:靶向自噬相关蛋白VPS34以增强基于STING激动剂的疗法

Bartolini, Elisabetta; Van Moer, Kris; Janji, Bassam

Modulating antibody effector functions by Fc glycoengineering

通过Fc糖基化工程调节抗体效应功能

García-Alija, Mikel; van Moer, Berre; Sastre, Diego E; Azzam, Tala; Du, Jonathan J; Trastoy, Beatriz; Callewaert, Nico; Sundberg, Eric J; Guerin, Marcelo E

The β-carboline Harmine improves the therapeutic benefit of anti-PD1 in melanoma by increasing the MHC-I-dependent antigen presentation

β-咔啉类化合物哈尔明通过增强MHC-I依赖性抗原呈递,提高抗PD-1药物在黑色素瘤中的治疗效果。

Muhammad Zaeem Noman ,Irene Adelaide Bocci ,Manale Karam ,Kris Van Moer ,Manon Bosseler ,Akinchan Kumar ,Guy Berchem ,Christian Auclair ,Bassam Janji

SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC

SNAI1依赖性CD73上调增加细胞外腺苷释放,从而介导三阴性乳腺癌的免疫抑制。

Meriem Hasmim ,Malina Xiao ,Kris Van Moer ,Akinchan Kumar ,Alexandra Oniga ,Michel Mittelbronn ,Caroline Duhem ,Anwar Chammout ,Guy Berchem ,Jean Paul Thiery ,Marianna Volpert ,Brett Hollier ,Muhammad Zaeem Noman ,Bassam Janji